KERALA AYURVEDA
|
The Current P/E Ratio of KERALA AYURVEDA is -609.63.
Share Price | ₹313.5 | Apr 30,2024 |
Market Cap | ₹376.1 Cr | |
Earnings-TTM | ₹-0.6 Cr | TTM-Consolidated Results |
Price/Earnings | -609.63x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of KERALA AYURVEDA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹376.1 Cr] as on Apr 30,2024
(/) Earnings [ ₹-0.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -609.63x ]
Thus, for KERALA AYURVEDA , the investors are currently willing to pay -609.63 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KERALA AYURVEDA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KERALA AYURVEDA over the last five years.
Historical PE (Price/Earnings) ratio chart of KERALA AYURVEDA
PE Ratio Performance Analysis for KERALA AYURVEDA
- KERALA AYURVEDA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 14.74x.
- KERALA AYURVEDA 's operated at median p/e ratio of 9.91x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KERALA AYURVEDA 's p/e ratio peaked in Mar2022 at 34.93x.
- KERALA AYURVEDA 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does KERALA AYURVEDA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
KERALA AYURVEDA | -0.62 | -609.63 | 376.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.06 | 360,452.0 |
CIPLA LTD | 3,744.03 | 30.22 | 113,132.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.87 | 103,512.0 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 32.48 | 95,954.5 |
DIVIS LABORATORIES LTD | 1,382.97 | 76.78 | 106,191.0 |
MANKIND PHARMA LTD | 1,743.30 | 54.37 | 94,779.2 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 59.81 | 89,363.1 |
LUPIN LTD | 1,809.74 | 41.44 | 74,991.4 |
AUROBINDO PHARMA LTD | 2,777.89 | 24.31 | 67,526.5 |
ABBOTT INDIA LTD | 1,145.58 | 49.00 | 56,131.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KERALA AYURVEDA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -609.63x |
Max industry PE | 76.78x |
Median industry PE | 40.06x |
Average industry PE | -16.48x |
You may also like the below Video Courses